Specific genetic variations, including those in PNPLA3, TM6SF2, and MBOAT7, linked to lean NAFLD, are also associated with an elevated risk of HCC (73). This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.